Nash DT, Fillit H: Cardiovascular disease risk factors and cognitive impairment. Am J Cardiol. 2006, 97 (8): 1262-1265. 10.1016/j.amjcard.2005.12.031.
Article
PubMed
Google Scholar
Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R: Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology. 2005, 65 (4): 545-551. 10.1212/01.wnl.0000172914.08967.dc.
Article
CAS
PubMed
PubMed Central
Google Scholar
Newman AB, Fitzpatrick AL, Lopez O, Jackson S, Lyketsos C, Jagust W, Ives D, Dekosky ST, Kuller LH: Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc. 2005, 53 (7): 1101-1107. 10.1111/j.1532-5415.2005.53360.x.
Article
PubMed
Google Scholar
Breteler MM, Claus JJ, Grobbee DE, Hofman A: Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. Bmj. 1994, 308 (6944): 1604-1608.
Article
CAS
PubMed
PubMed Central
Google Scholar
Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, Tschanz JT, Mayer LS, Welsh-Bohmer KA, Breitner JC: Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol. 2006, 63 (5): 686-692. 10.1001/archneur.63.5.noc60013.
Article
PubMed
Google Scholar
Skoog I, Lithell H, Hansson L, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A: Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE). Am J Hypertens. 2005, 18 (8): 1052-1059. 10.1016/j.amjhyper.2005.02.013.
Article
CAS
PubMed
Google Scholar
Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, Bossini A, Fagard R, Gil-Extremera B, Laks T, et al: The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002, 162 (18): 2046-2052. 10.1001/archinte.162.18.2046.
Article
PubMed
Google Scholar
Qiu C, Winblad B, Fratiglioni L: The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005, 4 (8): 487-499. 10.1016/S1474-4422(05)70141-1.
Article
PubMed
Google Scholar
Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G: Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol. 2000, 57 (10): 1439-1443. 10.1001/archneur.57.10.1439.
Article
CAS
PubMed
Google Scholar
Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA: Statins and the risk of dementia. Lancet. 2000, 356 (9242): 1627-1631. 10.1016/S0140-6736(00)03155-X.
Article
CAS
PubMed
Google Scholar
Rea TD, Breitner JC, Psaty BM, Fitzpatrick AL, Lopez OL, Newman AB, Hazzard WR, Zandi PP, Burke GL, Lyketsos CG, et al: Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol. 2005, 62 (7): 1047-1051. 10.1001/archneur.62.7.1047.
Article
PubMed
Google Scholar
Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Browne P, Wasser D, Johnson-Traver S, Lochhead J, Ziolwolski C: Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol. 2005, 62 (5): 753-757. 10.1001/archneur.62.5.753.
Article
PubMed
Google Scholar
Yaffe K, Barrett-Connor E, Lin F, Grady D: Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol. 2002, 59 (3): 378-384. 10.1001/archneur.59.3.378.
Article
PubMed
Google Scholar
Simons M, Schwarzler F, Lutjohann D, Von Bergmann K, Beyreuther K, Dichgans J, Wormstall H, Hartmann T, Schulz JB: Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol. 2002, 52 (3): 346-350. 10.1002/ana.10292.
Article
CAS
PubMed
Google Scholar
Rockwood K, Kirkland S, Hogan DB, MacKnight C, Merry H, Verreault R, Wolfson C, McDowell I: Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol. 2002, 59 (2): 223-227. 10.1001/archneur.59.2.223.
Article
PubMed
Google Scholar
Sjogren M, Mielke M, Gustafson D, Zandi P, Skoog I: Cholesterol and Alzheimer's disease – is there a relation?. Mech Ageing Dev. 2006, 127 (2): 138-147. 10.1016/j.mad.2005.09.020.
Article
PubMed
Google Scholar
Zandi P, Sparks L, Khachaturian A, et al: Do Statins Reduce Risk of Incident Dementia and AD? The Cache County Study. Arch Gen Psychiatry. 2004, 62: 217-224. 10.1001/archpsyc.62.2.217.
Article
Google Scholar
Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, et al: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002, 360 (9346): 1623-1630. 10.1016/S0140-6736(02)11600-X.
Article
CAS
PubMed
Google Scholar
Group HPSC: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002, 360 (9326): 7-22. 10.1016/S0140-6736(02)09327-3.
Article
Google Scholar
Smith MW, Joseph GJ: Pharmacy data in the VA health care system. Med Care Res Rev. 2003, 60 (3 Suppl): 92S-123S. 10.1177/1077558703256726.
Article
PubMed
Google Scholar
Sohn MW, Zhang H, Arnold N, Stroupe K, Taylor BC, Wilt TJ, Hynes DM: Transition to the new race/ethnicity data collection standards in the Department of Veterans Affairs. Popul Health Metr. 2006, 4: 7-10.1186/1478-7954-4-7.
Article
PubMed
PubMed Central
Google Scholar
Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992, 45 (6): 613-619. 10.1016/0895-4356(92)90133-8.
Article
CAS
PubMed
Google Scholar
Griffin G: Antiplatelet therapy and anticoagulation in patients with hypertension. Am Fam Physician. 2005, 71 (5): 897-899.
PubMed
Google Scholar
Blumenthal RS: Statins: effective antiatherosclerotic therapy. Am Heart J. 2000, 139 (4): 577-583. 10.1016/S0002-8703(00)90033-4.
Article
CAS
PubMed
Google Scholar
Gresser U, Gathof BS: Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke – comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies. Eur J Med Res. 2004, 9 (1): 1-17.
CAS
PubMed
Google Scholar
Krishnan LL, Petersen NJ, Snow AL, Cully JA, Schulz PE, Graham DP, Morgan RO, Braun U, Moffett ML, Yu HJ, et al: Prevalence of dementia among Veterans Affairs medical care system users. Dement Geriatr Cogn Disord. 2005, 20 (4): 245-253. 10.1159/000087345.
Article
PubMed
Google Scholar
Zhou Z, Rahme E, Pilote L: Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention. Am Heart J. 2006, 151 (2): 273-281. 10.1016/j.ahj.2005.04.003.
Article
CAS
PubMed
Google Scholar
Davidson MH: Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome. Am J Cardiol. 2004, 93 (11A): 3C-11C. 10.1016/j.amjcard.2004.02.006.
Article
CAS
PubMed
Google Scholar
Hunninghake DB, Ballantyne CM, Maccubbin DL, Shah AK, Gumbiner B, Mitchel YB: Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome. Clin Ther. 2003, 25 (6): 1670-1686. 10.1016/S0149-2918(03)80162-5.
Article
CAS
PubMed
Google Scholar
Karalis DG, Ross AM, Vacari RM, Zarren H, Scott R: Comparison of efficacy and safety of atorvastatin and simvastatin in patients with dyslipidemia with and without coronary heart disease. Am J Cardiol. 2002, 89 (6): 667-671. 10.1016/S0002-9149(01)02337-2.
Article
CAS
PubMed
Google Scholar
Vuletic S, Riekse RG, Marcovina SM, Peskind ER, Hazzard WR, Albers JJ: Statins of Different Brain Penetrability Differentially Affect CSF PLTP Activity. Dement Geriatr Cogn Disord. 2006, 22 (5–6): 392-398. 10.1159/000095679.
Article
CAS
PubMed
Google Scholar
Saheki A, Terasaki T, Tamai I, Tsuji A: In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Pharm Res. 1994, 11 (2): 305-311. 10.1023/A:1018975928974.
Article
CAS
PubMed
Google Scholar
Hawkins BT, Davis TP: The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005, 57 (2): 173-185. 10.1124/pr.57.2.4.
Article
CAS
PubMed
Google Scholar
Sironi L, Gianazza E, Gelosa P, Guerrini U, Nobili E, Gianella A, Cremonesi B, Paoletti R, Tremoli E: Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects. Arterioscler Thromb Vasc Biol. 2005, 25 (3): 598-603. 10.1161/01.ATV.0000157145.98200.55.
Article
CAS
PubMed
Google Scholar
Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, Szarek M, Libby P, Ganz P: High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation. 2003, 108 (13): 1560-1566. 10.1161/01.CIR.0000091404.09558.AF.
Article
CAS
PubMed
Google Scholar
Flockhart DA, Tanus-Santos JE: Implications of cytochrome P450 interactions when prescribing medication for hypertension. Arch Intern Med. 2002, 162 (4): 405-412. 10.1001/archinte.162.4.405.
Article
CAS
PubMed
Google Scholar
Bottorff MB: Statin safety and drug interactions: clinical implications. Am J Cardiol. 2006, 97 (8A): 27C-31C. 10.1016/j.amjcard.2005.12.007.
Article
CAS
PubMed
Google Scholar
Cesari M, Pessina AC: Combined antihypertensive and lipid-lowering treatment. Curr Hypertens Rep. 2004, 6 (4): 300-306. 10.1007/s11906-004-0025-5.
Article
PubMed
Google Scholar
Chan P, Huang TY, Tomlinson B, Lee C, Lee YS: Short-term safety and efficacy of low-dose simvastatin in elderly patients with hypertensive hypercholesterolemia and fasting hyperinsulinemia. J Clin Pharmacol. 1997, 37 (6): 496-501.
Article
CAS
PubMed
Google Scholar
Scranton RE, Young M, Lawler E, Solomon D, Gagnon D, Gaziano JM: Statin use and fracture risk: study of a US veterans population. Arch Intern Med. 2005, 165 (17): 2007-2012. 10.1001/archinte.165.17.2007.
Article
PubMed
Google Scholar
Wang PS, Solomon DH, Mogun H, Avorn J: HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. Jama. 2000, 283 (24): 3211-3216. 10.1001/jama.283.24.3211.
Article
CAS
PubMed
Google Scholar
Marz W, Koenig W: HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?. J Cardiovasc Risk. 2003, 10 (3): 169-179. 10.1097/00043798-200306000-00004.
Article
PubMed
Google Scholar
Wolozin B, Mange J, Bryant R, Cordy J, Green R, McKee A: Cholesterol, Alzheimer's disease and Statins: Re-assessing the relationship between cholesterol, statins and Alzheimer's disease. Acta Neuropathol Scandanavia. 2006, 185: 63-70. 10.1111/j.1600-0404.2006.00687.x.
Article
CAS
Google Scholar